Catalog No.
DHC36903
Expression system
Mammalian Cells
Species reactivity
Human
Host species
Humanized
Isotype
IgG1-kappa
Clonality
Monoclonal
Target
sIL6R, Interleukin-6 receptor subunit alpha, CD126, IL-6R 1, IL-6R subunit alpha, Membrane glycoprotein 80, gp80, IL6R, IL-6RA, IL-6 receptor subunit alpha, IL-6R-alpha
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P08887
Applications
Research Grade Biosimilar
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names
BCD-089, CAS: 2035008-70-7
Clone ID
Levilimab
Antibodies to watch in 2021, PMID: 33459118
Interleukin-6 blocking agents for treating COVID-19: a living systematic review, PMID: 33734435
Efficacy and Safety of Levilimab in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis: 56-Week Results of Phase III Randomized Double-Blind Placebo-Controlled Trial SOLAR., PMID:39196526
[Efficacy and safety of levilimab in the treatment of patients with rheumatoid arthritis]., PMID:39106512
Interleukin-6 blocking agents for treating COVID-19: a living systematic review., PMID:37260086
[Clinical cases of complicated diverticulitis against the background of severe course COVID-19. Case report]., PMID:37167171
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis., PMID:36368906
[Experience of anticipatory therapy with IL-6 receptor inhibitors and perspectives for its use in the evolution of COVID-19]., PMID:36286985
[Levilimab and baricitinib prescribing experience in outpatient COVID-19 patients' treatment]., PMID:36286967
The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study., PMID:34586459
Interleukin-6 blocking agents for treating COVID-19: a living systematic review., PMID:33734435
Antibodies to watch in 2021., PMID:33459118
For research use only. Not for human or drug use.
